Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors

NCT02313012 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
19
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celgene